Adding docetaxel to radiation therapy improved survival outcomes in cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma, a phase III randomised trial showed.

In efforts to speed workflow, improve patient care and augment an increasingly shorthanded clinical workforce, AI is starting to see wider adoption across healthcare. But there are questions regarding who is liable if an AI application fails and it results in a malpractice lawsuit.

Bhvita Jani, research manager at Signify Research, explains the technology trends she is seeing in the radiology X-ray market. She includes insights on digital radiography (DR), computed radiography (CR) and how the prices of digital detectors dropping have increased adoption of DR systems.

Stereotactic body radiotherapy (SBRT) guided by MRI for localised prostate cancer resulted in fewer toxicities and an improvement in quality of life compared with CT guidance, according to the randomised phase III MIRAGE trial.

Given the long- and short-term harms of opioids, cardiac surgeons stressed that it is feasible to put strict limits around perioperative opioid use without giving up pain control and patient satisfaction.

Building on his ASNC 2022 meeting president-elect address, Al-Mallah’s article in the Journal of Nuclear Cardiology urges readers to embrace the “significant innovations” that nuclear cardiology has seen in the past decade.

Here is a list of some key trends in radiology technology from the editors of Health Imaging and Radiology Business that clinicians should be aware of heading into 2023.

A short course of perioperative chemotherapy for locally advanced esophageal/gastroesophageal junction (GEJ) cancer led to outcomes similar to those achieved with more intensive multimodal therapy, according to a randomised trial reported here.

The bivalent COVID-19 booster targeting BA.4/5 showed high levels of protection against COVID-19 hospitalisation in older adults, an observational cohort study out of Israel showed.

Two artificial intelligence (AI) programs, including ChatGPT, have passed the U.S. Medical Licensing Examination (USMLE), according to two recent papers.